Rarity Bioscience
Rarity Bioscience provides multiplex assays for detecting nucleic acid sequences in biological samples like liquid biopsies.
Rarity Bioscience operates in biotechnology, health care, medical based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2021.
Its activity falls under biotechnology, health care, medical; the profile below is assembled from public directory data.
The company is recorded as being based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
The company is listed at the Seed stage of development.
The company reports a headcount in the c_00001_00010 range.
Total disclosed funding stands at about $3M.
| Sector | Biotechnology, Health Care, Medical |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2021 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $3,000,000 |
Website: raritybioscience.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account